Cancer Patients Who Receive Neoadjuvant Therapy Followed By Mastectomy May Not Need Radiation Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M. D. Anderson Cancer Center. The findings were reported at the 50th Annual meeting of the American Society for Therapeutic Radiology and Oncology.
Source: www.medicalnewstoday.comNovel Mechanism To Reduce Nervous System Inflammation Identified By Researchers Researchers at Georgetown University Medical Center have discovered a new way to limit inflammation caused by the activation of microglia - key immune cells in the brain. Although the role of such cells is to "clean up damage" after injury, they often worsen the damage by releasing toxic inflammatory factors.
Source: www.medicalnewstoday.comSelective Deletion Of Rett Syndrome Gene Provides Insight Into Origin Of Complex Behaviors A new study describes an exciting approach for mapping the specific neuronal origins of complex and varied behaviors characteristic of Rett syndrome (RTT), an autism spectrum disorder. The research, published by Cell Press in the September 25th issue of the journal Neuron, also uncovers a novel and unexpected role for the gene that causes RTT.
Source: www.medicalnewstoday.comCardiac Arrest Survival Rate Varies By Region, Study Shows The survival chances of people who go into cardiac arrest outside of a hospital vary from region to region throughout the U.S. and Canada, according to a study published on Wednesday in the Journal of the American Medical Association, the Boston Globe reports.
Source: www.medicalnewstoday.comBisphosphonates Cause Rare Eye Inflammation Title: Bisphosphonates Cause Rare Eye Inflammation
Category:
Health News
Created: 9/25/2008 2:00:00 AM
Last Editorial Review: 9/25/2008
Source: www.medicinenet.comA Physician's Assessment Of Depression Can Be Hampered By His Personality A physician's personality can affect practice behavior in inquiries about patient mood symptoms and the diagnosis of depression, according to a study led by University of Rochester Medical Center researchers. "Some doctors, due to their personal preferences, traits or attitudes, are loathe to broach sensitive topics such as depression or suicide," said Paul R. Duberstein, Ph.D.
Source: www.medicalnewstoday.comLow Sensitivity Of Clinical Signatures Genomic signature sequences used by clinical researchers to detect, quantify and diagnose nucleic acid sequences are not inclusive enough. New research published in BioMed Central's open access journal Annals of Clinical Microbiology and Antimicrobials shows that many published sequences are of unacceptably low sensitivity for most clinical applications.
Source: www.medicalnewstoday.comVA To Provide Full Benefits For All Veterans With ALS The Department of Veterans Affairs on Tuesday announced that all veterans with amyotrophic lateral sclerosis, or Lou Gehrig's disease, will receive full disability, lifetime
health and death benefits, a move that effectively acknowledges a general link between the condition and military service, the New York Times reports.
Source: www.medicalnewstoday.comStates Should Seek To Encourage Adoption Of Health Care Information Technology, Report Recommends States should coordinate with
health care providers, industry and the federal government to expand adoption of
health care information technology, according to a report released on Tuesday by the State Alliance for E-
Health, a panel established by the National Governors Association, CongressDaily reports.
Source: www.medicalnewstoday.comInitiation Of Clinical Trials Of CPI-613 For The Treatment Of Cancer - First-In-Class Altered Energy Metabolism-Directed Compound Cornerstone Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has begun dosing patients in a recently approved safety and early efficacy clinical trial of CPI-613, its novel first-in-class Altered Energy Metabolism-Directed (AEMD) compound being evaluated for potential use in a wide array of cancers.
Source: www.medicalnewstoday.com
# posted by Network @ 6:00 PM
